MS
DVAX

Maven Securities’s Dynavax Technologies DVAX Stock Holding History

Maven Securities’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-264,989
Closed -$931K – 374
2019
Q3 		$931K Buy
+264,989
New +$1.03M 0.29% 90

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Maven Securities's DVAX Position: Q4 2019 in Review

Maven Securities sold out of Dynavax Technologies (DVAX) in Q4 2019, closing a stake of 264,989 shares — an estimated $931K sold.

Maven Securities first reported a position in DVAX in Q3 2019 and held it in 1 quarter. The position peaked at $931K in Q3 2019. 123 funds tracked by Wall St. Rank hold DVAX as of Q4 2019.

  • Maven Securities reported no remaining Dynavax Technologies position as of Q4 2019 after selling out during the quarter.
  • Maven Securities sold 264,989 Dynavax Technologies shares in Q4 2019, an estimated $931K.
  • Maven Securities first reported a position in Dynavax Technologies in Q3 2019 and held it in 1 quarter.
  • Maven Securities's Dynavax Technologies position peaked at $931K in Q3 2019.
  • 123 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2019.

Based on Maven Securities's 13F filing for Q4 2019, filed 14 Feb 2020.